BIONTECH SE SPON ADS EACH REP 1 ORD SHS (BNTX) - Price, trends, fundamentals and chart - Passport to Wall Street

BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ: BNTX)

Overview

current price

$91.66

$91.66

change

-3.49 | -3.67%

-3.49 | -3.67%

Yesterday's Close

95.15

open

95.68

volume

0.67 M

30d. avg volume.

1.92 M

1 day

91.29 - 96.67

52 weeks

28.00 - 131.00

p/e

0.00

beta

0.0000

market cap

22.66 B

dividend yield

0.00%

Industry

-

News and Commentary

Biden Says U.S. Will Have Enough Vaccine Doses For Every Adult in May President Joe Biden announced on Tuesday that the United States has now secured enough vaccine doses for every adult in the country to be fully vaccinated by the end of May.

Stock and Health Care ETFs Boosted by Johnson & Johnson's Vaccine E.U.A. The regulatory approval of the Johnson & Johnson (

F.D.A. Approves Johnson & Johnson's One-Shot COVID Vaccine for Emergency Use On Saturday, the U.S. Food and Drug Administration (F.D.A.)

Market Update: Stocks Rise Higher on Vaccine Optimism and Improved Risk Sentiment Stocks jumped on Monday in a broad-market rally as investors were encouraged by renewed vaccine optimism and risk sentiment rose on retreating U.S. Treasury yields. The Dow Jones...

Pfizer and BioNTech to Study COVID Vaccine Booster Shots Pfizer (PFE

U.S. Retail Sales Expected to Rise as Much as 8.2% in 2021, says NRF U.S. retail sales are expected to rise as much as 8.2% to more than $4.33 trillion this year as the economy begins to fully reopen and more people get the coronavirus vaccine, th...

The U.S. Surpasses 500,000 Coronavirus Death Toll in One Year In about one year into the coronavirus pandemic, the United States death toll has surpassed the grim milestone of 500,000. Currently, the U.S. has reported more deaths than any o...

F.D.A. Will Not Require Long Clinical Trials for Coronavirus Vaccines Modified for Variant Strains The U.S. Food and Drug Administration (F.D.A.) announced on Monday that modified coronavirus vaccines developed to protect against new, emerging variants of SARS-CoV-2 may be aut...

Biden Administration Secures 200 Million More Moderna, Pfizer Vaccine Doses President Joe Biden announced on Thursday that the United States will have enough coronavirus vaccines by the end of the summer to inoculate 300 million Americans, which is most...

About 10% of U.S. Population Received at least One COVID Vaccine Dose Nearly 33 million people in the United States have received at least one dose of the coronavirus vaccine, according to

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more